Covance (NYSE: CVD) today announced the availability of the Covance Express SuiteSM of Interactive Voice Response Services (IVRS) — affordable, fast start-up IVRS solutions for small, non-complex clinical trials. The Express Suite comprises pre-configured solutions to address the most common patient enrollment, randomization, and drug supply management needs of biopharmaceutical firms sponsoring trials and studies where automated methods have not previously been a viable or cost-effective option. The Express Suite provides sponsors with a study-wide view of patient and drug supply activity enabling them to monitor progress, anticipate problems, and take preventive actions before they occur.
